These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36978470)

  • 41. Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
    Huhulescu S; Sagel U; Fiedler A; Pecavar V; Blaschitz M; Wewalka G; Allerberger F; Indra A
    J Med Microbiol; 2011 Aug; 60(Pt 8):1206-1212. PubMed ID: 21292853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefiderocol for treatment of an empyema due to extensively drug-resistant
    Kufel WD; Steele JM; Riddell SW; Jones Z; Shakeraneh P; Endy TP
    IDCases; 2020; 21():e00863. PubMed ID: 32577400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparision of Colistin Broth Disc Elution, Rapid Resapolymyxin NP and Broth Microdilution Methods in Determining Colistin Sensitivity in Acinetobacter, Pseudomonas and Enterobacterales species].
    Sarıkaya A; Mumcuoğlu İ; Baran I; Aksoy A; Dinç B
    Mikrobiyol Bul; 2022 Jul; 56(3):404-415. PubMed ID: 35960234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a Commercial Broth Microdilution Panel for Colistin Susceptibility Testing of Clinical Isolates of Escherichia coli and Klebsiella pneumoniae.
    Mirza HC; Bıçakçıgil A; Liste Ü; Sancak B
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the BD Phoenix100 System and Colistin Broth Disk Elution Method for Antimicrobial Susceptibility Testing of Colistin Against Gram-negative Bacteria].
    Koyuncu Özyurt Ö; Özhak B; Öğünç D; Yıldız E; Çolak D; Günseren F; Öngüt G
    Mikrobiyol Bul; 2019 Jul; 53(3):254-261. PubMed ID: 31414627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens from Germany.
    Kresken M; Korte-Berwanger M; Gatermann SG; Pfeifer Y; Pfennigwerth N; Seifert H; Werner G
    Int J Antimicrob Agents; 2020 Oct; 56(4):106128. PubMed ID: 32758648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefiderocol - An effective antimicrobial for MDR infections but a challenge for routine antimicrobial susceptibility testing.
    Brauncajs M; Bielec F; Macieja A; Pastuszak-Lewandoska D
    Adv Med Sci; 2024 May; 69(2):256-263. PubMed ID: 38782257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing
    Bovo F; Lazzarotto T; Ambretti S; Gaibani P
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
    Bianco G; Boattini M; Comini S; Casale R; Iannaccone M; Cavallo R; Costa C
    Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):573-580. PubMed ID: 35061145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms.
    Bianco G; Gaibani P; Comini S; Boattini M; Banche G; Costa C; Cavallo R; Nordmann P
    Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline.
    Babaei S; Haeili M
    BMC Infect Dis; 2021 Jul; 21(1):709. PubMed ID: 34315422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa.
    Mojica MF; De La Cadena E; Hernández-Gómez C; Correa A; Appel TM; Pallares CJ; Villegas MV
    J Glob Antimicrob Resist; 2020 Jun; 21():391-395. PubMed ID: 32004722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
    Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
    J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans.
    Gajic I; Ranin L; Kekic D; Opavski N; Smitran A; Mijac V; Jovanovic S; Hadnadjev M; Travar M; Mijovic G
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):176-181. PubMed ID: 32160781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible
    Zhang J; Jia P; Zhu Y; Zhang G; Xu Y; Yang Q
    Front Med (Lausanne); 2021; 8():643194. PubMed ID: 33937287
    [No Abstract]   [Full Text] [Related]  

  • 59. 'Breakpoint broth microdilution plate' for susceptibility testing of Gram negative bacilli against colistin sulfate.
    Ahmed I; Laiq S; Shaheen N; Wahab K; Farooqi J; Shahid A; Hasan R; Shakoor S
    Pract Lab Med; 2020 Nov; 22():e00192. PubMed ID: 33299918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany.
    Thelen P; Henriksen AS; Longshaw C; Yamano Y; Caldwell B; Hamprecht A
    J Glob Antimicrob Resist; 2022 Mar; 28():12-17. PubMed ID: 34920174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.